These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23841449)

  • 1. High-throughput differentiation of heparin from other glycosaminoglycans by pyrolysis mass spectrometry.
    Nemes P; Hoover WJ; Keire DA
    Anal Chem; 2013 Aug; 85(15):7405-12. PubMed ID: 23841449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-hour screening of adulterated heparin by simplified peroxide digestion and fast RPIP-LC-MS(2).
    Li H; Wickramasekara S; Nemes P
    Anal Chem; 2015 Aug; 87(16):8424-32. PubMed ID: 26168275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
    Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ
    J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
    Hu P; Fang L; Chess EK
    Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations.
    Volpi N; Buzzega D
    J Pharm Biomed Anal; 2012; 67-68():144-7. PubMed ID: 22534509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive detection of oversulfated chondroitin sulfate in heparin sodium or crude heparin with a colorimetric microplate based assay.
    Sommers CD; Mans DJ; Mecker LC; Keire DA
    Anal Chem; 2011 May; 83(9):3422-30. PubMed ID: 21449571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants.
    Tami C; Puig M; Reepmeyer JC; Ye H; D'Avignon DA; Buhse L; Verthelyi D
    Biomaterials; 2008 Dec; 29(36):4808-14. PubMed ID: 18801571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
    Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of possible economically motivated adulterants in heparin sodium and low molecular weight heparins with a colorimetric microplate based assay.
    Sommers CD; Keire DA
    Anal Chem; 2011 Sep; 83(18):7102-8. PubMed ID: 21819047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Chem; 2011 Feb; 83(3):1030-9. PubMed ID: 21192734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins.
    Alban S; Lühn S; Schiemann S
    Anal Bioanal Chem; 2011 Jan; 399(2):681-90. PubMed ID: 20953779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
    Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
    Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
    Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.
    Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T
    Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of 1H NMR spectra.
    Rudd TR; Gaudesi D; Lima MA; Skidmore MA; Mulloy B; Torri G; Nader HB; Guerrini M; Yates EA
    Analyst; 2011 Apr; 136(7):1390-8. PubMed ID: 21279244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Chemically Sulfated/desulfated Glycosaminoglycans in Contaminated Heparins and Development of a Simple Assay for the Detection of Most Contaminants in Heparin.
    Pan J; Qian Y; Zhou X; Pazandak A; Frazier SB; Weiser P; Lu H; Zhang L
    Glycobiol Insights; 2010 Feb; 2010(2):1-12. PubMed ID: 20657729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.
    Volpi N; Maccari F; Linhardt RJ
    Anal Biochem; 2009 May; 388(1):140-5. PubMed ID: 19232311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Beacon-Based Fluorescent Assay for Specific Detection of Oversulfated Chondroitin Sulfate Contaminants in Heparin without Enzyme Treatment.
    Lee CY; Tseng WL
    Anal Chem; 2015; 87(10):5031-5. PubMed ID: 25927411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.